Cancers of the colon and rectum

Schottenfeld and Fraumeni Cancer Epidemiology and Prevention, Fourth Edition

Volumn , Issue , 2017, Pages 681-706

  Wu, Kana ^a   Keum, Nana ^a   Nishihara, Reiko ^b   Giovannucci, Edward L ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Colorectal cancer; Detection; Diet; Obesity; Prevention; Screening

Indexed keywords

EID: 85051015475     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/oso/9780190238667.003.0036     Document Type: Chapter

References (378)

1. Aarts MJ, Lemmens VE, Louwman MW, Kunst AE, and Coebergh JW. 2010. Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur J Cancer, 46(15), 2681-2695 .PMID: 20570136.
2. Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, and Bostick RM. 2012. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/B-catenin pathway in the normal mucosa of colorectal adenoma patients. Cancer Prev Res (Phila), 5(10), 1247-1256 .PMCID: PMC3466388.
3. Alberts DS, Martinez ME, Hess LM, et al. 2005. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst, 97(11), 846-853 .PMID: 15928305.
4. Aleksandrova K, Pischon T, Buijsse B, et al. 2013. Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer, 49(16), 3526-3536 .PMID: 23867126.
5. Aleksandrova K, Pischon T, Jenab M, et al. 2014. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med, 12, 168 .PMCID: PMC4192278.
6. Alexander DD, Miller AJ, Cushing CA, and Lowe KA. 2010. Processed meat and colorectal cancer: a quantitative review of prospective epidemiologic studies. Eur J Cancer Prev, 19(5), 328-341 .PMID: 20495462.
7. Alexander DD, Weed DL, Miller P, and Mohamed M. 2015. Red meat and colorectal cancer: aquantitative update on the state of the epidemiologic science. J Am Coll Nutrition, 34(6), 521-543 .PMCID: PMC4673592.
8. American Institute for Cancer Research. 2007. Chapter 7.9. Colon and Rectum. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR, pages 280-288.
9. Ananthakrishnan AN, Du M, Berndt SI, et al. 2015. Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies. Cancer Epidemiol Biomarkers Prev .PMCID: PMC4294960.
10. Andersen V, Holst R, and Vogel U. 2013. Systematic review: diet-gene interac-tions and the risk of colorectal cancer. Aliment Pharmacol Ther, 37(4), 383-391 .PMCID: PMC3565452.
11. Andersen V, and Vogel U. 2015. Interactions between meat intake and genetic variation in relation to colorectal cancer. Genes Nutr, 10(1), 448 .PMCID: PMC4261072.
12. Arain MA, Sawhney M, Sheikh S, et al. 2010. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol, 105(5), 11891195 .PMID: 20010923.
13. Armstrong B, and Doll R. 1975. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer, 15(4), 617-631 .PMID: 1140864.
14. Asano TK, and McLeod RS. 2004. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review. Dis Colon Rectum, 47(5), 665-673 .PMID: 15054679.
15. Aune D, Chan DS, Lau R, et al. 2011. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ, 343, d6617 .PMCID: PMC3213242.
16. Azcarate-Peril MA, Sikes M, and Bruno-Barcena JM. 2011. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol, 301(3), G401-G424 .PMCID: PMC3774253.
17. Bailey CE, Hu CY, You YN, et al. 2015. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg, 150(1), 17-22 .PMCID: PMC4666003.
18. Barault L, Charon-Barra C, Jooste V, et al. 2008. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res, 68(20), 8541-8546 .PMID: 18922929.
19. Baron JA. 2005. Dietary fiber and colorectal cancer: an ongoing saga. JAMA, 294(22), 2904-2906 .PMID: 16352800.
20. Baron JA, Barry EL, Mott LA, et al. 2015. A trial of calcium and vitamin d for the prevention of colorectal adenomas. N Engl J Med, 373(16), 15191530 .PMCID: PMC4643064.
21. Bastide NM, Pierre FH, and Corpet DE. 2011. Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev Res (Phila), 4(2), 177-184 .PMID: 21209396.
22. Baxter RC. 2014. IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer, 14(5), 329-341 .PMID: 24722429.
23. Bernstein AM, Song M, Zhang X, et al. 2015. Processed and unprocessed red meat and risk of colorectal cancer: analysis by tumor location and modification by time. PLoS One, 10(8), e0135959 .PMCID: PMC4549221.
24. Bernstein AM, Sun Q, Hu FB, et al. 2010. Major dietary protein sources and risk of coronary heart disease in women. Circulation, 122(9), 876-883 .PMCID: PMC2946797.
25. Bernstein H, Bernstein C, Payne CM, Dvorakova K, and Garewal H. 2005. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res, 589(1), 47-65 .PMID: 15652226.
26. Bibbins-Domingo K, Grossman D, Curry S, et al. 2016. Screening for colorectal cancer: US Preventitive Services Task Force recommendation statement. JAMA, 315(23), 2564-2575 .PMID: 27304597.
27. Bingham SA. 1999. High-meat diets and cancer risk. Proc Nutr Soc, 58(2), 243-248 .PMID: 10466162.
28. Bisgaard ML, Fenger K, Bulow S, Niebuhr E, and Mohr J. 1994. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat, 3(2), 121-125 .PMID: 8199592.
29. Bissonnette M, Khare S, von Lintig FC, et al. 2000. Mutational and non- mutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Cancer Res, 60(16), 4602-4609 Bibunstruct / .PMID: 10969813.
30. Bonser AM, and Garcia-Webb P. 1984. C-peptide measurement: methods and clinical utility. Crit Rev Clin Lab Sci, 19(4), 297-352 .PMID: 6373142.
31. Botteri E, Iodice S, Bagnardi V, et al. 2008a. Smoking and colorectal cancer: a meta-analysis. JAMA, 300(23), 2765-2778 .PMID: 19088354.
32. Botteri E, Iodice S, Raimondi S, Maisonneuve P, and Lowenfels AB. 2008b. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology, 134(2), 388-395 .PMID: 18242207.
33. Bouvard V, Loomis D, Guyton KZ, et al. 2015. Carcinogenicity of consumption of red and processed meat. Lancet Oncol, 16(16), 1599-1600 .PMID: 26514947.
34. Boyle T, Keegel T, Bull F, Heyworth J, and Fritschi L. 2012. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst, 104(20), 1548-1561 .PMID: 22914790.
35. Brenner H, Chang-Claude J, Rickert A, Seiler CM, and Hoffmeister M. 2012. Risk of colorectal cancer after detection and removal of adenomas at colonoscopy: population-based case-control study. J Clin Oncol, 30(24), 2969-2976 .PMID: 22826281.
36. Brenner H, Chang-Claude J, Seiler CM, and Hoffmeister M. 2011. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol, 29(28), 3761-3767 .PMID: 21876077.
37. Brentnall TA, Crispin DA, Rabinovitch PS, et al. 1994. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology, 107(2), 369-378 .PMID: 8039614.
38. Bristow SM, Bolland MJ, MacLennan GS, et al. 2013. Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials. Br J Nutr, 110(8), 1384-1393 .PMID: 23601861.
39. Bufill JA. 1990. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med, 113(10), 779- 788 .PMID: 2240880.
40. Burkitt DP. 1969. Related disease: related cause? Lancet, 2(7632), 1229-1231 .PMID: 4187817.
41. Buset M, Kipkin M, Winawer S, Swaroop S, and Friedman E. 1986. Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium. Cancer Res, 46(10), 5426-5430 .PMID: 3756891.
42. Butterworth AS, Higgins JP, and Pharoah P. 2006. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer, 42(2), 216-227 .PMID: 16338133.
43. Canavan C, Abrams KR, and Mayberry J. 2006. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther, 23(8), 1097-1104 .PMID: 16611269.
44. Carethers JM, and Jung BH. 2015. Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology, 149(5), 1177-1190 PMCID: PMC4589489.
45. Carr PR, Walter V, Brenner H, and Hoffmeister M. 2016. Meat subtypes and their association with colorectal cancer: systematic review and metaanalysis. Int J Cancer, 138(2), 293-302 .PMID: 25583132.
46. Cats A, Dullaart RP, Kleibeuker JH, et al. 1996. Increased epithelial cell pro-liferation in the colon of patients with acromegaly. Cancer Res, 56(3), 523-526 .PMID: 8564965.
47. Center MM, Jemal A, and Ward E. 2009. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18(6), 1688-1694 .PMID: 19505900.
48. Centers for Disease Control. 2014. The Health Consequences of Smoking- 50 years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention.
49. Centers for Disease Control. 2015. Colorectal cancer rates by race and ethnicity. Available from: http://www.cdc.gov/cancer/colorectal/statistics/race. htm Accessed January 2016.
50. Chan AT, Giovannucci EL, Meyerhardt JA, et al. 2005. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA, 294(8), 914-923 .PMCID: PMC1550973.
51. Chan AT, Ogino S, Fuchs CS. 2007. Aspirin and the risk of colorectal cancer in relation to the expression of Cox-2. N Engl J Med, 356(21), 2131-2142 .PMID: 17522398.
52. Chan AT, Ogino S, and Fuchs CS. 2009. Aspirin use and survival after diagnosis of colorectal cancer. JAMA, 302(6), 649-659 .PMCID: PMC2848289.
53. Chan DS, Lau R, Aune D et al. 2011. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One, 6(6), e20456 .PMCID: PMC3108955.
54. Chen L, Li L, Wang Y et al. 2013. Circulating C-peptide level is a predictive fac-tor for colorectal neoplasia: evidence from the meta-analysis of prospective studies. Cancer Causes Control, 24(10), 1837-1847 .PMID: 23846284.
55. Cho E, Smith-Warner SA, Ritz J, et al. 2004a. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med, 140(8), 603-613 .PMID: 15096331.
56. Cho E, Smith-Warner SA, Spiegelman D, et al. 2004b. Dairy foods and calcium and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst, 96(13), 1015-1022 .PMID: 15240785.
57. Citronberg J, Kantor ED, Potter JD, and White E. 2014. A prospective study of the effect of bowel movement frequency, constipation, and laxative use on colorectal cancer risk. Am J Gastroenterol, 109(10), 1640-1649 .PMCID: PMC4734897.
58. Clemmons DR. 1997. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev, 8(1), 45-62 .PMID: 9174662.
59. Colao A, Pivonello R, Auriemma RS, et al. 2007. The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients. J Clin Endocrinol Metab, 92(10), 3854-3860 .PMID: 17652220.
60. Cole BF, Logan RF, Halabi S, et al. 2009. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst, 101(4), 256-266 .PMID: 19211452.
61. Cook NR, Lee IM, Gaziano JM, et al. 2005. Low-dose aspirin in the primary prevention of cancer the women's health study: a randomized controlled trial. JAMA, 294(1), 47-55 .PMID: 15998890.
62. Cook NR, Lee IM, Zhang SM, Moorthy MV, and Buring JE. 2013. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med, 159(2), 77-85 .PMCID: PMC3713531.
63. Cotton S, Sharp L, and Little J. 1996. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog, 7(5- 6), 293-342 .PMID: 9467664.
64. Coussens LM, and Werb Z. 2002. Inflammation and cancer. Nature, 420(6917), 860-867 .PMCID: PMC2803035.
65. Cress RD, Morris C, Ellison GL, and Goodman MT. 2006. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001. Cancer, 107(5 Suppl), 1142-1152 .PMID: 16835912.
66. Cross AJ, Ferrucci LM, Risch A, et al. 2010. A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res, 70(6), 2406-2414 .PMCID: PMC2840051.
67. Cross AJ, Pollock JR, and Bingham SA. 2003. Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res, 63(10), 2358-2360 .PMID: 12750250.
68. Cross AJ, and Sinha R. 2004. Meat-related mutagens/carcinogens in the etiology of colorectal cancer. Environ Mol Mutagen, 44(1), 44-55 .PMID: 15199546.
69. Cucino C, Buchner AM, and Sonnenberg A. 2002. Continued rightward shift of colorectal cancer. Dis Colon Rectum, 45(8), 1035-1040 .PMID: 12195187.
70. Cummings LC, and Cooper GS. 2011. Colorectal cancer screening: update for 2011. Semin Oncol, 38(4), 483-489 .PMID: 21810507.
71. Curtin K, Samowitz WS, Wolff RK, et al. 2009. Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer, 125(1), 158-164 .PMCID: PMC2782655.
72. Debinski HS, Love S, Spigelman AD, and Phillips RK. 1996. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology, 110(4), 1028-1030 .PMID: 8612989.
73. DeFronzo RA. 1992. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia, 35(4), 389-397 .PMID: 1516769.
74. Dellavalle CT, Xiao Q, Yang G, et al. 2014. Dietary nitrate and nitrite intake and risk of colorectal cancer in the Shanghai Women's Health Study. Int J Cancer, 134(12), 2917-2926 .PMCID: PMC3980001.
75. DeMarini DM. 2004. Genotoxicity of Tobacco smoke and Tobacco smoke con-densate: a review. Mutat Res, 567(2-3), 447-474 .PMID: 15572290.
76. Despres JP. 2006. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J Suppl, 8(B), B4-B12.
77. Dirx MJ, van den Brandt PA, Goldbohm RA, and Lumey LH. 2003. Energy restriction early in life and colon carcinoma risk: results of The Netherlands Cohort Study after 7.3 years of follow-up. Cancer, 97(1), 46-55 .PMID: 12491504.
78. Doll R, Gray R, Hafner B, and Peto R. 1980. Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J, 280(6219), 967-971 .PMCID: PMC1601142.
79. Doll R, and Peto R. 1976. Mortality in relation to smoking: 20 years' obser-vations on male British doctors. Br Med J, 2(6051), 1525-1536 .PMCID: PMC1690096.
80. Domingo E, Church DN, Sieber O, et al. 2013. Evalution of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. J Clin Oncol, 31(34), 4297-4305 .PMID: 24062397.
81. Dozois EJ, Suwanthanma W, et al. 2008. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine (Baltimore), 87(5), 259-263 .PMCID: PMC4437192.
82. Duffy LC, Raiten DJ, Hubbard VS, and Starke-Reed P. 2015. Progress and chal-lenges in developing metabolic footprints from diet in human gut microbial cometabolism. J Nutr, 145(5), 1123S-1130S .PMCID: PMC4410496.
83. Eaden J. 2004. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther, 20(4), 24-30 .PMID: 15352890.
84. Egeberg R, Olsen A, Christensen J, et al. 2013. Associations between red meat and risks for colon and rectal cancer depend on the type of red meat consumed. J Nutr, 143(4), 464-472 .PMID: 23427329.
85. Ekbom A, Yuen J, Adami HO, et al. 1993. Cholecystectomy and colorectal cancer. Gastroenterology, 105(1), 142-147 .PMID: 8514031.
86. Elmunzer BJ, Hayward RA, Schoenfeld PS, et al. 2012. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med, 9(12), e1001352 .PMCID: PMC3514315.
87. Engeland A, Tretli S, Austad G, and Bjorge T. 2005. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control, 16(8), 987-996 .PMID: 16132807.
88. Erdrich J, Zhang X, Giovannucci E, and Willett W. 2015. Proportion of colon cancer attributable to lifestyle in a cohort of US women. Cancer Causes Control, 26(9), 1271-1279 .PMCID: PMC4545459.
89. Fearnhead NS, Britton MP, and Bodmer WF. 2001. The ABC of APC. Hum Mol Genet, 10(7), 721-733 .PMID: 11257105.
90. Fearon ER, and Vogelstein B. 1990. A genetic model for colorectal tumorigen- esis. Cell, 61(5), 759-767 .PMID: 2188735.
91. Fedirko V, Riboli E, Tjonneland A, et al. 2012. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations. Cancer Epidemiol Biomarkers Prev, 21(4), 582-593 .PMCID: PMC3378514.
92. Feldman D, Krishnan AV, Swami S, Giovannucci E, and Feldman BJ. 2014. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer, 14(5), 342-357 .PMID: 24705652.
93. Flood DM, Weiss NS, Cook LS, et al. 2000. Colorectal cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control, 11(5), 403-411 .PMID: 10877333.
94. Flossmann E, and Rothwell PM. 2007. Commentary: aspirin and colorectal cancer an epidemiological success story. Int J Epidemiol, 36(5), 962-965 .PMID: 17954716.
95. Friedenreich CM, and Orenstein MR. 2002. Physical activity and cancer pre-vention: etiologic evidence and biological mechanisms. J Nutr, 132(11 Suppl), 3456S-3464S .PMID: 12421870.
96. Fuemmeler BF, Pendzich MK, and Tercyak KP. 2009. Weight, dietary behavior, and physical activity in childhood and adolescence: implications for adult cancer risk. Obes Facts, 2(3), 179-186 .PMCID: PMC2924235.
97. Fung TT, and Brown LS. 2013. Dietary patterns and the risk of colorectal cancer. Curr Nutr Rep, 2(1), 48-55 .PMCID: PMC3649851.
98. Gagniere J, Raisch J, Veziant J, et al. 2016. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol, 22(2), 501-518 .PMCID: PMC4716055.
99. Gala MK, and Chan AT. 2015. Molecular pathways: aspirin and Wnt signaling- a molecularly targeted approach to cancer prevention and treatment. Clin Cancer Res, 21(7), 1543-1548 .PMCID: PMC4383688.
100. Gao QY, Chen HM, Chen YX, et al. 2013. Folic acid prevents the initial occur-rence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial. Cancer Prev Res (Phila), 6(7), 744-752 .PMID: 23682073.
101. Garland CF, and Garland FC. 1980. Do sunlight and vitamin D reduce the like-lihood of colon cancer? Int J Epidemiol, 9(3), 227-231 .PMID: 7440046.
102. Gay LJ, Mitrou PN, Keen J, et al. 2012. Dietary, lifestyle and clinicopathologi- cal factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC-Norfolk study. J Pathol, 228(3), 405-415 .PMID: 22864938.
103. Geer EB, and Shen W. 2009. Gender differences in insulin resistance, body composition, and energy balance. Gend Med, 6(Suppl 1), 60-75 .PMCID: PMC2908522.
104. Giovannucci E. 2001a. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr, 131(11 Suppl), 3109S-3120S .PMID: 11694656.
105. Giovannucci E. 2001b. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 10(7), 725-731 .PMID: 11440957.
106. Giovannucci E. 2004. Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J Nutr, 134(9), 2475S-2481S .PMID: 15333745.
107. Giovannucci E. 2007. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr, 86(3), s836-s842 .PMID: 18265477.
108. Giovannucci E. 2009. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol, 19(2), 84-88 .PMID: 18291673.
109. Giovannucci E. 2013. Epidemiology of vitamin D and colorectal cancer. Anticancer Agents Med Chem, 13(1), 11-19 .PMID: 23094917.
110. Giovannucci E, Ascherio A, Rimm EB, et al. 1995. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med, 122(5), 327-334 .PMID: 7847643.
111. Giovannucci E, Colditz GA, and Stampfer MJ. 1993. A meta-analysis of chole-cystectomy and risk of colorectal cancer. Gastroenterology, 105(1), 130-141 .PMID: 8514030.
112. Giovannucci E, Colditz GA, Stampfer MJ, et al. 1994. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst, 86(3), 192-199 .PMID: 8283491.
113. Giovannucci E, Colditz GA, Stampfer MJ, and Willett WC. 1996. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control, 7(2), 253-263 .PMID: 8740738.
114. Giovannucci E, Harlan DM, Archer MC, et al. 2010. Diabetes and cancer: a consensus report. CA Cancer J Clin, 60(4), 207-221 .PMID: 20554718.
115. Giovannucci E, Pollak MN, Platz EA, et al. 2000. A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev, 9(4), 345-349 .PMID: 10794477.
116. Giovannucci E, and Wu K. 2006. Cancers of the colon and rectum. In: Schottenfeld D, and Fraumeni J (Eds.), Cancer Epidemiology and Prevention (3rd ed.). New York: Oxford University Press.
117. Goldbohm RA, Van den Brandt PA, van't Veer P, et al. 1993. Cholecystectomy and colorectal cancer: evidence from a cohort study on diet and cancer. Int J Cancer, 53(5), 735-739 .PMID: 8449596.
118. Green J, Cairns BJ, Casabonne D, et al. 2011. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol, 12(8), 785-794 .PMCID: PMC3148429.
119. Grundy SM. 1999. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol, 83(9B), 25F-29F .PMID: 10357572.
120. Guinney J, Dienstmann R, Wang X, et al. 2015. The consensus molecular subtypes of colorectal cancer. Nat Med, 21(11), 1350-1356 .PMCID: PMC4636487.
121. Haenszel W, and Kurihara M. 1968. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst, 40(1), 43-68 .PMID: 5635018.
122. Hamilton MT, Hamilton DG, and Zderic TW. 2007. Role of low energy expen-diture and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes, 56(11), 2655-2667 .PMID: 17827399.
123. Hamilton SR, Liu B, Parsons RE, et al. 1995. The molecular basis of Turcot's syndrome. N Engl J Med, 332(13), 839-847 .PMID: 7661930.
124. Hammond CE, and Horn D. 1966. Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monog, 19, 127-204 .PMID: 5905667.
125. Hammond EC, and Horn D. 1958. Smoking and death rates: report on forty- four months of followup of 187,783 men. II. Death rates by causality. J Am Med Assoc, 166(11), 1294-1308 .PMID: 12308037.
126. Hannan LM, Jacobs EJ, and Thun MJ. 2009. The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomarkers Prev, 18(12), 3362-3367 .PMID: 19959683.
127. Harriss DJ, Cable NT, George K, et al. 2007. Physical activity before and after diagnosis of colorectal cancer: disease risk, clinical outcomes, response pathways and biomarkers. Sports Med, 37(11), 947-960 .PMID: 17953466. =1130&Sectio nid=79747222. Accessed November 21, 2016.
128. He TC, Sparks AB, Rago C, et al. 1998. Identification of c-MYC as a target of the APC pathway. Science, 281(5382), 1509-1512 .PMID: 9727977.
129. Heitman SJ, Ronksley PE, Hilsden RJ, et al. 2009. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol, 7(12), 1272-1278 .PMID: 19523536.
130. Herman JG, Umar A, Polyak LK, et al. 1998. Incidence and functional conse-quences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A, 95(12), 6870-6875 .PMCID: PMC22665.
131. Hewitson P, Glasziou P, Irwig L, Towler B, and Watson E. 2007. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 1, CD001216 .PMID: 17253456.
132. Hewitson P, Glasziou P, Watson E, Towler B, and Irwig L. 2008. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol, 103(3), 1541-1549 .PMID: 18479499.
133. Hillman RS, and Steinberg SE. 1982. The effects of alcohol on folate metabolism. Ann Rev Med, 33, 345-354 .PMID: 6805415.
134. Hjartaker A, Aagnes B, Robsahm TE, et al. 2013. Subsite-specific dietary risk factors for colorectal cancer: a review of cohort studies. J Oncol, 2013, 703-854 .PMCID: PMC3610350.
135. Hoffmann D, and Hoffman I. 1997. The changing cigarette, 1950-1995. J Toxicol Environ Health, 50(4), 307-364 .PMID: 9120872.
136. Hol L, van Leerdam ME, van Ballegooijen M et al. 2010. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut, 59(1), 62-68 .PMID: 19671542.
137. Holme O, Bretthauer M, Eide TJ, et al. 2015. Long-ierm risk of colorectal cancer in individuals with serrated polyps. Gut, 64(6), 929-936 .PMID: 25399542.
138. Hord NG, Tang Y, and Bryan NS. 2009. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr, 90(1), 1-10 .PMID: 19439460.
139. Houlston RS, and Tomlinson IP. 2001. Polymorphisms and colorectal tumor risk. Gastroenterology, 121(2), 282-301 .PMID: 11487538.
140. Howard RA, Freedman DM, Park Y, et al. 2008. Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control, 19(9), 939-953 .PMCID: PMC2574900.
141. Hsing AW, McLaughlin JK, Chow WH, et al. 1998. Risk factors for colorectal cancer in a prospective study among U.S. white men. Int J Cancer, 77(4), 549-553 .PMID: 9679757.
142. Hu FB. 2002. Dietary pattern analysis: a new direction in nutritional epidemiol-ogy. Curr Opin Lipidol, 13(1), 3-9 .PMID: 11790957.
143. Hu FB, Manson JE, Liu S, et al. 1999. Prospective study of adult onset diabetes mellitus (Type 2) and risk of colorectal cancer in women. J Natl Cancer Inst, 91(6), 542-547 .PMID: 10088625.
144. Hughes LA, van den Brandt PA, Goldbohm RA, et al. 2010. Childhood and ado-lescent energy restriction and subsequent colorectal cancer risk: results from the Netherlands Cohort Study. Int J Epidemiol, 39(5), 1333-1344 .PMID: 20427463.
145. Huxley RR, Ansary-Moghaddam A, Clifton P, et al. 2009. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer, 125(1), 171-180 .PMID: 19350627.
146. Iacopetta B. 2002. Are there two sides to colorectal cancer? Int J Cancer, 101(5), 403-408 .PMID: 12216066.
147. Imperiale TF, Ransohoff DF, and Itzkowitz SH. 2014. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med, 371(2), 187-188 .PMID: 25006736.
148. Institute of Medicine National Cancer Policy. 2008. Implementing Colorectal Cancer Screening: Workshop Summary. Washington, DC: National Academies Press.
149. International Agency for Research on Cancer. 2010. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans Alcohol Consumption and Ethyl Carbamate. Lyon, France: International Agency for Research on Cancer.
150. International Agency for Research on Cancer/World Health Organization. 2015. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed January 5, 2016.
151. Irving BA, Davis CK, Brock DW et al. 2008. Effect of exercise training intensity on abdominal visceral fat and body composition. Med Sci Sports Exerc, 40(11), 1863-1872 .PMCID: PMC2730190.
152. Jass JR. 2007. Molecular heterogeneity of colorectal cancer: implications for cancer control. Surg Oncol, 16(Suppl 1), S7-S9 .PMID: 18023574.
153. Jeffreys M, Smith GD, Martin RM, Frankel S, and Gunnell D. 2004. Childhood body mass index and later cancer risk: a 50-year follow-up of the Boyd Orr study. Int J Cancer, 112(2), 348-351 .PMID: 15352051.
154. Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al. 2010. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ, 340, b5500 .PMCID: PMC2809840.
155. Jenkins PJ. (1999). Acromegaly and Colon Cancer. Paper presented at the First International Workshop on Growth Hormone, Insulin-iike Growth Factors and Neoplasia, Boston, MA .PMID: 10984286.
156. Johns LE, and Houlston RS. 2001. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol, 96(10), 2992-3003 .PMID: 11693338.
157. Johnson CM, Wei C, Ensor JE, et al. 2013. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control, 24(6), 1207-1222 .PMCID: PMC4161278.
158. Jokelainen K, Nosova T, Koivisto T, et al. 1997. Inhibition of bacteriocolonic pathway for ethanol oxidation by ciprofloxacin in rats. Life Sci, 61(18), 1755-1762 .PMID: 9365222.
159. Juul A, Main K, Blum WF, et al. 1994. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf), 41(1), 85-93 .PMID: 7519529.
160. Kaaks R, and Lukanova A. 2001. Energy balance and cancer: the role of insulin and insulin-iike growth factor-I. Proc Nutr Soc, 60(1), 91-106 .PMID: 11310428.
161. Kaaks R, Toniolo P, Akhmedkhanov A, et al. 2000. Serum C-peptide, insulinlike growth factor (IGF)-1, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst, 92(19), 1592-1600 .PMID: 11018095.
162. Kahn HA. 1966. The Dorn study of smoking and mortality among U.S. veterans: report on eight and one-half years of observation. Natl Cancer Inst Monogr, 19, 1-125 .PMID: 5905668.
163. Kang GH. 2011. Four molecular subtypes of colorectal cancer and their precursor lesions. Arch Pathol Lab Med, 135(6), 698-703 .PMID: 21631262.
164. Kantor ED, Hutter CM, Minnier J, et al. 2014. Gene-environment interaction involving recently identified colorectal cancer susceptibility loci. Cancer Epidemiol Biomarkers Prev, 23(9), 1824-1833 .PMCID: PMC4209726.
165. Keum N, Aune D, Greenwood DC, Ju W, and Giovannucci EL. 2014. Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies. Int J Cancer, 135(8), 1940-1948 .PMID: 24623471.
166. Keum N, and Giovannucci EL. 2014. Folic acid fortification and colorectal cancer risk. Am J Prev Med, 46(3 Suppl 1), S65-S72 .PMID: 24512932.
167. Keum N, Greenwood DC, Lee DH et al. 2015. Adult weight gain and adiposity- related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst, 107(3) .PMID: 25618901.
168. Keum N, Lee DH, Kim R, Greenwood DC, and Giovannucci EL. 2015. Visceral adiposity and colorectal adenomas: dose-response metaanalysis of observational studies. Ann Oncol, 26(6), 1101-1109 .PMID: 25480876.
169. Kim DH, Smith-Warner SA, Spiegelman D, et al. 2010. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control, 21(11), 1919-1930 .PMCID: PMC3082430.
170. Kim YI. 2006. Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut, 55(10), 1387-1389 .PMCID: PMC1856406.
171. Kinzler KW, and Vogelstein B. 1996. Lessons from hereditary colorectal cancer. Cell, 87(2), 159-170 .PMID: 8861899.
172. Knekt P, Jarvinen R, Dich J, and Hakulinen T. 1999. Risk of colorectal and other gastro-i ntestinal cancers after exposure to nitrate, nitrite and N- nitroso compounds: a follow-up study. Int J Cancer, 80(6), 852-856 .PMID: 10074917.
173. Kojima M, Wakai K, Tokudome S, et al. 2004. Bowel movement frequency and risk of colorectal cancer in a large cohort study of Japanese men and women. Br J Cancer, 90(7), 1397-1401 .PMCID: PMC2409677.
174. Kono S, Shinchi K, Ikeda N, Yanai F, and Imanishi K. 1991. Physical activity, dietary habits and adenomatous polyps of the sigmoid colon: a study of self-defense officials in Japan. 44(11), 1255-1261 .PMID: 1941019.
175. Kritchevsky D. 1995. Epidemiology of fibre, resistant starch and colorectal cancer. Eur J Cancer Prev, 4(5), 345-352 .PMID: 7496322.
176. Kuchiba A, Morikawa T, Yamauchi M, et al. 2012. Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. J Natl Cancer Inst, 104(5), 415-420 .PMCID: PMC3295745.
177. Kune GA. 2010. The Melbourne Colorectal Cancer Study: reflections on a 30- year experience. Med J Aust, 193(11-12), 648-652 .PMID: 21143050.
178. Kushi LH, Doyle C, McCullough M, et al. 2012. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin, 62(1), 30-67 .PMID: 22237782.
179. Lampe JW, Fredstrom SB, Slavin JL, and Potter JD. 1993. Sex differences in colonic function: a randomised trial. Gut, 34(4), 531-536 .PMCID: PMC1374316.
180. Lamprecht SA, and Lipkin M. 2001. Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci, 952, 73-87 .PMID: 11795445.
181. Larsson SC, and Wolk A. 2006. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer, 119(11), 2657-2664 .PMID: 16991129.
182. Laryea JA, Siegel E, and Klimberg S. 2014. Racial disparity in colorectal cancer: the role of equal treatment. Dis Colon Rectum, 57(3), 295-302 .PMID: 24509450.
183. Le NT, Michels FA, Song M, et al. 2016. A prospective analysis of meat mutagens and colorectal cancer in the Nurses' Health Study and Health Professional Follow-up Study. Environ Health Perspect, (Epub ahead of print) .PMID: 27105317.
184. Lee C, Kozlowski JM, and Grayhack JT. 1995. Etiology of benign prostatic hyperplasia. Urol Clin North Am, 22(2), 237-246 .PMID: 7539172.
185. Lee JE, Willett WC, Fuchs CS, et al. 2011. Folate intake and risk of colorectal cancer and adenoma: modification by time. Am J Clin Nutr, 93(4), 817-825 .PMCID: PMC3057549.
186. Lemire M, Qu C, Loo LW, et al. 2015. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. Hum Genet, 134(11-12), 1249-1262 .PMCID: PMC4687971.
187. Lennerz JK, Sloot KW, Le LP, et al. 2016. Colorectal cancer in Crogn's colitis is comparable to sporadic colorectal cancer. Int J Colorectal Dis, 31(5), 973-982 .PMID: 27026089.
188. Leufkens AM, Duijnhoven FJ, Boshuizen HC, et al. 2012. Educational level and risk of colorectal cancer in EPIC with specific reference to tumor location. Int J Cancer, 130(3), 622-630 .PMID: 21412763.
189. Lev R. 1990. Adenomatous Polyps of the Colon(p. 61). NewYork: Springer-Verlag.
190. Levi Z, Kark JD, Barchana M, et al. 2011. Measured body mass index in ado-lescence and the incidence of colorectal cancer in a cohort of 1.1 million males. Cancer Epidemiol Biomarkers Prev, 20(12), 2524-2531 .PMID: 22056504.
191. Levin B, and Raijman I. 1995. Malignant tumors of the colon and rectum. In: Haubrich W S, Schaffner F, and Berk J (Eds.), Bockus Gastroenterology (5th ed., pp. 1744-1772). Philadelphia: Saunders.
192. Liang PS, Chen TY, and Giovannucci E. 2009. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer, 124(10), 2406-2415 .PMID: 19142968.
193. Liao XY, Lochhead P, Nishihara R, et al. 2012. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med, 367(17), 1596 PMCID: PMC3532946.
194. Lieberman DA, Rex DK, Winawer SJ, et al. 2012. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology, 143(3), 844-857 .PMID: 22763141.
195. Lilienfeld AM, Levin ML, and Kessler II. 1972a. Mortality among the foreign born and their countries of origin. In: Cancer in the United States (pp. 233-278). Cambridge, MA: Harvard University Press.
196. Lilienfeld AM, Levin ML, and Kessler II. 1972b. Summary of mortality data for selected sites. In: Cancer in the United States (pp. 279-297). Cambridge, MA: Harvard University Press.
197. Limsui D, Vierkant RA, Tillmans LS, et al. 2010. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst, 102(14), 1012-1022 .PMCID: PMC2915616.
198. Lin KJ, Cheung WY, Lai JY, and Giovannucci EL. 2012. The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer, 130(2), 419-430 .PMID: 21365647.
199. Little J, Logan RF, Hawtin PG, Hardcastle JD, and Turner ID. 1993. Colorectal adenomas and energy intake, body size and physical activity: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br J Cancer, 67(1), 172-176 .PMCID: PMC1968212.
200. Littlejohn C, Hilton S, Macfarlane GJ, and Phull P. 2012. Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer. Br J Surg, 99(11), 1488- 500 .PMID: 23001715.
201. Loberg M, Kalager M, Holme O, et al. 2014. Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med, 371(9), 799-807 .PMID: 25162886.
202. Lochhead P, Chan AT, Giovannucci E, et al. 2014. Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions. Am J Gastroenterol, 109(8), 1205-1214 .PMCID: PMC4125459.
203. Luo S, Li JY, Zhao LN, et al. 2016. Diabetes mellitus increases the risk of colorectal neoplasia: an updated meta-analysis. Clin Res Hepatol Gastroenterol, 40(1), 110-123 .PMID: 26162991.
204. Lynch HT, and Smyrk T. 1996. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review. Cancer, 78(6), 1149-1167 .PMID: 8826936.
205. Lynch HT, and Smyrk T. 1998. An update on Lynch syndrome. Curr Opin Oncol, 10(4), 349-356 .PMID: 9702403.
206. Lynch HT, Smyrk T, and Jass JR. 1995. Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? Semin Surg Oncol, 11(6), 406-410 .PMID: 8607009.
207. Ma J, Pollak MN, Giovannucci E, et al. 1999. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF- binding protein-3. J Natl Cancer Inst, 91(7), 620-625 .PMID: 10203281.
208. MacInnis RJ, English DR, Hopper JL, et al. 2004. Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev, 13(4), 553-559 .PMID: 15066919.
209. Magalhaes B, Peleteiro B, and Lunet N. 2012. Dietary patterns and colorectal cancer: systematic review and meta-analysis. Eur J Cancer Prev, 21(1), 15-23 .PMID: 21946864.
210. Manser CN, and Bauerfeind P. 2014. Impact of socioeconomic status on incidence, mortality, and survival of colorectal cancer patients: a systematic review. Gastrointest Endosc, 80(1), 42-60 .PMID: 24950641.
211. Marisa L, Reynies A, Duval A, et al. 2013. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med, 10(5), e1001453 .PMCID: PMC3660251.
212. Markowitz SD, and Bertagnolli MM. 2009. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med, 361(25), 2449-2460 .PMCID: PMC2843693.
213. Martinez ME, Giovannucci E, Spiegelman D, et al. 1996. Physical activity, body size, and colorectal cancer in women (Abstract). Am J Epidemiol, 143, S73.
214. Maskarinec G, and Noh JJ. 2004. The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis, 14(3), 431-439 .PMID: 15328946.
215. Mason JB, Dickstein A, Jacques PF, et al. 2007. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev, 16(7), 1325-1329 .PMID: 17626997.
216. McCredie M, Williams S, and Coates M. 1999. Cancer mortality in migrants from the British Isles and continental Europe to New South Wales, Australia, 1975-1995. Int J Cancer, 83(2), 179-185 .PMID: 10471524.
217. McGlynn AP, Wasson GR, O'Reilly SL, et al. 2013. Low colonocyte folate is associated with uracil misincorporation and global DNA hypometh- ylation in human colorectum. J Nutr, 143(1), 27-33 .PMID: 23190761.
218. McMichael AJ, and Potter JD. 1985. Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst, 75(2), 185-191 .PMID: 3894750.
219. Meyskens FL, McLaren CE, Pelot D, et al. 2008. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila), 1(1), 32-38 .PMCID: PMC2562024.
220. Michels KB, Fuchs CS, Giovannucci E, et al. 2005. Fiber intake and incidence of colorectal cancer among 76,947 women and 47,279 men. Cancer Epidemiol Biomarkers Prev, 14(4), 842-849 .PMID: 15824154.
221. Moghaddam AA, Woodward M, and Huxley R. 2007. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev, 16(12), 2533-2547 .PMID: 18086756.
222. Morikawa T, Kuchiba A, Lochhead P, et al. 2013. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with p-catenin (CTNNB1) status. Cancer Res, 73(5), 1600-1610 .PMCID: PMC3594537.
223. Muller A, and Fishel R. 2002. Mismatch repair and the hereditary nonpolyposis colorectal cancer syndrome (HNPCC). Cancer Invest, 20(1), 102-109 .PMID: 11852992.
224. Murphy CC, Harlan LC, Warren JL, and Geiger AM. 2015. Race and insurance differences in the receipt of adjuvant chemotherapy among patients with stage III colon cancer. J Clin Oncol, 33(23), 2530-2536 .PMCID: PMC4525047.
225. Murthy S, Flanigan A, and Clearfield H. 2002. Colorectal cancer in inflammatory bowel disease: molecular and clinical features. Gastroenterol Clin North Am, 31(2), 551-564 .PMID: 12134618.
226. Myers EA, Feingold DL, Forde KA, et al. 2013. Colorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions' experience. World J Gastroenterol, 19(34), 5651-5657 .PMCID: PMC3769901.
227. Nan H, Hutter CM, Lin Y, et al. 2015. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA, 313(11), 1133-1142 .PMCID: PMC4382867.
228. Neugut AI, Jacobson JS, and De Vivo I. 1993. Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev, 2(2), 159-176 .PMID: 8467251.
229. Neugut AI, Terry MB, Hocking G, et al. 1996. Leisure and occupational physical activity and risk of colorectal adenomatous polyps. Int J Cancer, 68(6), 744-748 .PMID: 8980177.
230. Newmark HL, Wargovich MJ, and Bruce WR. 1984. Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J Natl Cancer Inst, 72(6), 1323-1325 .PMID: 6587152.
231. Nimptsch K, Giovannucci E, Willett WC, et al. 2011. Body fatness during childhood and adolescence, adult height, and risk of colorectal adenoma in women. Cancer Prev Res (Phila), 4(10), 1710-1718 .PMCID: PMC3188350.
232. Ning Y, Wang L, and Giovannucci EL. 2010. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev, 11(1), 19-30 .PMID: 19538439.
233. Nishihara R, Morikawa T, Kuchiba A, et al. 2013 a. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics- related tumor classification. Am J Epidemiol, 178(1), 84-100 .PMCID: PMC3698990.
234. Nishihara R, Wu K, Lochhead P, et al. 2013b. Long-t erm colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med, 369(12), 1095-1105 .PMCID: PMC3840160.
235. Norat T, Lukanova A, Ferrari P, and Riboli E. 2002. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer, 98(2), 241-256 .PMID: 11857415.
236. Nyren O, Bergstrom R, Nystrom L, et al. 1996. Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst, 88(18), 1302-1307 .PMID: 8797770.
237. O'Reilly SL, McGlynn AP, McNulty H, et al. 2016. Folic acid supplementation in postpolypectomy patients in a randomized controlled trial increases tissue folate concentrations and reduces aberrant DNA biomarkers in colonic tissues adjacent to the former polyp site. J Nutr, 146(5), 933-939 .PMID: 27075913.
238. Oettle GJ. 1991. Effect of moderate exercise on bowel habit. Gut, 32(8), 941-944 .PMCID: PMC1378967.
239. Ogino S, and Goel A. 2008. Molecular classification and correlates in colorectal cancer. J Mol Diagn, 10(1), 13-27 .PMCID: PMC2175539.
240. Ogino S, Kawasaki T, Kirkner GJ, et al. 2007. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn, 9(3), 305-314 .PMCID: PMC1899428.
241. Ollberding NJ, Cheng I, Wilkens LR, et al. 2012. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study. Cancer Epidemiol Biomarkers Prev, 21(5), 810-820 .PMCID: PMC4494075.
242. Ollberding NJ, Wilkens LR, Henderson BE, Kolonel LN, and Le Marchand L. 2012. Meat consumption, heterocyclic amines and colorectal cancer risk: the Multiethnic Cohort Study. Int J Cancer, 131(7), E1125-E1133 .PMCID: PMC3553660.
243. Orlando G, Law PJ, Palin K, et al. 2016. Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease. Hum Mol Genet, (Epub ahead of print) .PMID: 27005424.
244. Osterhues A, Holzgreve W, and Michels KB. 2009. Shall we put the world on folate? Lancet, 374(9694), 959-961 .PMID: 19766871.
245. Otani T, Iwasaki M, Ishihara J et al. 2006. Dietary fiber intake and subsequent risk of colorectal cancer: the Japan Public Health Center-based prospective study. Int J Cancer, 119(6), 1475-1480 .PMID: 16642466.
246. Otani T, Iwasaki M, Sasazuki S, et al. 2007. Plasma C-peptide, insulin-tike growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Int J Cancer, 120(9), 2007-2012 .PMID: 17266031.
247. Palmqvist R, Hallmans G, Rinaldi S, et al. 2002. Plasma insulin-tike growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut, 50(5), 642-646 .PMCID: PMC1773192.
248. Park JY, Mitrou PN, Keen J, et al. 2010. Lifestyle factors and p53 mutation patterns in colorectal cancer patients in the EPIC-Norfolk study. Mutagenesis, 25(4), 351-358 .PMID: 20228093.
249. Parkin D, Muir C, Whelan S, et al. 1992. Cancer incidence in five continents, comparability and quality of data. IARC Sci Publ, 143(120), 45-173 .PMID: 1284606.
250. Parr CL, Hjartaker A, Lund E, and Veierod MB. 2013. Meat intake, cooking methods and risk of proximal colon, distal colon and rectal cancer: the Norwegian Women and Cancer (NOWAC) cohort study. Int J Cancer, 133(5), 1153-1163 .PMID: 23401013.
251. Peltomaki P. 2001. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet, 10(7), 735-740 .PMID: 11257106.
252. Peters U, Hutter CM, Hsu L, et al. 2012. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet, 131(2), 217-234 .PMCID: PMC3257356.
253. Peters U, Jiao S, Schumacher FR, et al. 2013. Identification of genetic sus-ceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology, 144(4), 799-807 PMCID: PMC3636812.
254. Pham NM, Mizoue T, Tanaka K, et al. 2014. Meat consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol, 44(7), 641-650 .PMID: 24842864.
255. Pickhardt PJ, Hassan C, Halligan S, and Marmo R. 2011. Colorectal cancer: CT colonography and colonoscopy for detection: systematic review and meta-analysis. Radiology, 259(2), 393-405 .PMCID: PMC3079122.
256. Pierre FH, Martin OC, Santarelli RL, et al. 2013. Calcium and alpha-tocopherol suppress cured-meat promotion of chemically induced colon carcinogenesis in rats and reduce associated biomarkers in human volunteers. Am J Clin Nutr, 98(5), 1255-1262 .PMCID: PMC3798078.
257. Pino MS, and Chung DC. 2010. The chromosomal instability pathway in colon cancer. Gastroenterology, 138(6), 2059-2072 .PMCID: PMC4243705.
258. Pischon T, Lahmann PH, Boeing H, et al. 2006. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst, 98(13), 920-931 .PMID: 16818856.
259. Platz EA, Willett WC, Colditz GA, et al. 2000. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control, 11(7), 579-588 .PMID: 10977102.
260. Pollak M. 2008. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer, 8(12), 915-928 .PMID: 19029956.
261. Potischman N, and Linet MS. 2013. Invited commentary: are dietary intakes and other exposures in childhood and adolescence important for adult cancers? Am J Epidemiol, 178(2), 184-189 .PMCID: PMC3816339.
262. Potter JD, Bigler J, Fosdick L, et al. 1999. Colorectal adenomatous and hyper-plastic polyps: smoking and N-acetyltransferase 2 polymorphisms. Cancer Epidemiol Biomarkers Prev, 8(1), 69-75 .PMID: 9950242.
263. Poynter JN, Haile RW, Siegmund KD, et al. 2009. Associations between smok-ing, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev, 18(10), 2745-2750 .PMCID: PMC2759847.
264. Poynter JN, Siegmund KD, Weisenberger DJ, et al. 2008. Molecular char-acterization of MSI-H colorectal cancer by MLHI promoter myth- ylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev, 17(11), 3208-3215 .PMCID: PMC2628332.
265. Probst-Hensch NM, Yuan JM, Stanczyk FZ, et al. 2001. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer, 85(11), 1695-1699 .PMCID: PMC2363974.
266. Rajakariar R, Yaqoob MM, and Gilroy DW. 2006. COX-2 in inflammation and resolution. Mol Interv, 6(4), 199-207 .PMID: 16960142.
267. Rao SR, Breen N, and Graubard BI. 2015. Trends in black-white disparities in breast and colorectal cancer screening rates in a changing screening envi-ronment: the Peters-Belson approach using United States National Health Interview Surveys 2000-2010. Med Care, 54(2), 133-139 .PMID: 26565527.
268. Renehan AG, Painter JE, Atkin WS, et al. 2001. High-risk colorectal adenomas and serum insulin-iike growth factors. Br J Surg, 88(1), 107-113 .PMID: 11136321.
269. Rex DK, Ahnen DJ, Baron JA, et al. 2012. Serrated lesions of the col- orectum: review and recommendations from an expert panel. Am J Gastroenterol, 107(9), 1315-1329 .PMCID: PMC3629844.
270. Ridlon JM, Harris SC, Bhowmik S, Kang DJ, and Hylemon PB. 2016. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes, 7(1), 22-39 .PMCID: PMC4856454.
271. Ries LA, Wingo PA, Miller DS, et al. 2000. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer, 88(10), 2398-2424 .PMID: 10820364.
272. Rim SH, Seeff L, Ahmed F, King JB, and Coughlin SS. 2009. Colorectal cancer incidence in the United States, 1999-2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer, 115(9), 1967-1976 .PMID: 19235249.
273. Rinaldi S, Cleveland R, Norat T, et al. 2010. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a metaanalysis of prospective studies. Int J Cancer, 126(7), 1702-1715 .PMID: 19810099.
274. Robbins AS, Siegel RL, and Jemal A. 2012. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol, 30(4), 401-405 .PMID: 22184373.
275. Rodriguez-Bigas MA, Lin EH, and Crane CH. 2003. Stage IV colorectal cancer. In: Kufe D, Pollock R, Weichselbaum R, et al. (Eds.), Cancer Medicine (6th ed.).
276. Rogler G. 2014. Chronic ulcerative colitis and colorectal cancer. Cancer Lett, 345(2), 235-241 .PMID: 23941831.
277. Rogot E, and Murray JL. 1980. Smoking and causes of death among US Veterans: 16 years of observation. Public Health Rep, 95(3), 213-222 .PMCID: PMC1422715.
278. Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, and Koukoulis G. 2008. Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol, 14(22), 3484-3489 .PMCID: PMC2716609. '
279. Romano M, Francesco F, Zarantonello L, et al. 2016. From inflammation to cancer in inflammatory bowel disease: molecular perspectives. Anticancer Res, 36(4), 1447-1460 .PMID: 27069120.
280. Roncucci L, and Mariani F. 2015. Prevention of colorectal cancer: How many tools do we have in our basket? Eur J Intern Med, 26(10), 752-756 .PMID: 26499755.
281. Ross R, Dagnone D, Jones PJ, et al. 2000. Reduction in obesity and related comorbid conditions after diet-i nduced weight loss or exercise-i nduced weight loss in men: a randomized, controlled trial. Ann Intern Med, 133(2), 92-103 .PMID: 10896648.
282. Ross R, Janssen I, Dawson J, et al. 2004. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res, 12(5), 789-798 .PMID: 15166299.
283. Rosty C, Hewett DG, Brown IS, Leggett BA, and Whitehall VL. 2013. Serrated polyps of the large intestine: current understanding of diagnosis, patho-genesis, and clinical management. J Gastroenterol, 48(3), 287-302 .PMCID: PMC3698429.
284. Rothwell PM, Wilson M, Elwin CE, et al. 2010. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet, 376(9754), 1741-1750 .PMID: 20970847.
285. Salaspuro M. 2009. Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers. Scand J Gastroenterol, 44(8), 912-925 .PMID: 19396661.
286. Samowitz WS. 2008. Genetic and epigenetic change in colon cancer. Exp Mol Pathol, 85(1), 64-67 .PMID: 18482722.
287. Samowitz WS, Albertsen H, Herrick J et al. 2005. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology, 129(3), 837-845 .PMID: 16143123.
288. Samuels Y, Wang Z, Bardelli A et al. 2004. High frequency of mutations of the PIK3CA gene in human cancers. Science, 304(5670), 554 .PMID: 15016963.
289. Sandhu MS, Dunger DB, and Giovannucci EL. 2002. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst, 94(13), 972-980 .PMID: 12096082.
290. Sandhu MS, White IR, and McPherson K. 2001. Systematic review of the pro-spective cohort studies on meat consumption and colorectal cancer risk: a meta-analytic approach. Cancer Epidemiol Biomarkers Prev, 10(5), 439-446 .PMID: 11352852.
291. Santarelli RL, Naud N, Tache S, et al. 2013. Calcium inhibits promotion by hot dog of 1,2-dimethylhydrazine-induced mucin-depleted foci in rat colon. Int J Cancer, 133(11), 2533-2541 .PMCID: PMC3788046.
292. Santarelli RL, Pierre F, and Corpet DE. 2008. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer, 60(2), 131-144 .PMCID: PMC2661797.
293. Schatzkin A, Mouw T, Park Y, et al. 2007. Dietary fiber and whole-grain con-sumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr, 85(5), 1353-1360 .PMID: 17490973.
294. Schmid D, and Leitzmann MF. 2014. Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis. J Natl Cancer Inst, 106(7) .PMID: 24935969.
295. Schmit SL, Schumacher FR, Edlund CK et al. 2014. A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study. Carcinogenesis, 35(11), 2512-2519 .PMCID: PMC4271131.
296. Schoen RE, Pinsky PF, Weissfeld JL, et al. 2012. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med, 366(25), 2345-2357 .PMCID: PMC3641846.
297. Schoen RE, Tangen CM, Kuller LH, et al. 1999. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst, 91(13), 1147-1154 .PMID: 10393723.
298. Schreuders EH, Ruco A, Rabeneck L, et al. 2015. Colorectal cancer screening: a global overview of existing programmes. Gut, 64(10), 1637-1649 .PMID: 26041752.
299. Schumacher FR, Schmit SL, Jiao S, et al. 2015. Corrigendum: Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun, 6, 8739 .PMID: 26498495.
300. Sebastian C, and Mostoslavsky R. 2014. Untangling the fiber yarn: butyrate feeds warburg to suppress colorectal cancer. Cancer Discov, 4(12), 1368-1370 .PMCID: PMC4258833.
301. Sehdev A, and O'Neil BH. 2015. The role of aspirin, vitamin D, exercise, diet, statins, and metformin in the prevention and treatment of colorectal cancer. Curr Treat Options Oncol, 16(9), 43 .PMID: 26187794.
302. Seitz HK, and Becker P. 2007. Alcohol metabolism and cancer risk. Alcohol Res Health, 30(1), 38-41, 44-37 .PMCID: PMC3860434.
303. Shaukat A, Scouras N, and Schunemann HJ. 2005. Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials. Am J Gastroenterol, 100(2), 390-394 .PMID: 15667497.
304. Shen D, Mao W, Liu T, et al. 2014. Sedentary behavior and incident cancer: a meta-analysis of prospective studies. Plos One, 9(8), e105709 .PMCID: PMC4143275.
305. Shi Y, Yu PW, and Zeng DZ. 2015. Dose-response meta-analysis of poultry intake and colorectal cancer incidence and mortality. Eur J Nutr, 54(2), 243-250 .PMID: 24788671.
306. Siegel R, Desantis C, and Jemal A. 2014. Colorectal cancer statistics, 2014. CA Cancer J Clin, 64(2), 104-117 .PMID: 24639052.
307. Siegel RL, Jemal A, and Ward EM. 2009. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev, 18(6), 1695-1698 .PMID: 19505901.
308. Siegel RL, Miller KD, and Jemal A. 2015. Cancer statistics, 2015. CA Cancer J Clin, 65(1), 5-29 .PMID: 25559415.
309. Siegel RL, Miller KD, and Jemal A. 2016. Cancer statistics, 2016. CA Cancer J Clin, 66(1), 7-30 .PMID: 26742998.
310. Simons CC, Hughes LA, Smits KM, et al. 2013. A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. Ann Oncol, 24(8), 2048-2056 .PMID: 23532114.
311. Sinha R, and Norat T. 2002. Meat cooking and cancer risk. IARC Sci Publ, 156, 181-186 .PMID: 12484160.
312. Sinha R, Peters U, Cross AJ, et al. 2005. Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res, 65(17), 8034-8041 .PMID: 16140978.
313. Sinicrope FA, Shi Q, Smyrk TC, et al. 2015. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Gastroenterology, 148(1), 88-99 .PMCID: PMC4274188.
314. Slattery ML. 2000. Diet, lifestyle, and colon cancer. Semin Gastrointest Dis, 11(3), 142-146 .PMID: 10950460.
315. Slattery ML. 2004. Physical activity and colorectal cancer. Sports Med, 34(4), 239-252 .PMID: 15049716.
316. Slattery ML, Anderson K, Curtin K, et al. 2001. Lifestyle factors and Kiras mutations in colon cancer tumors. Mutat Res, 483(1-2), 73-81 .PMID: 11600135.
317. Slattery ML, Benson J, Berry TD, et al. 1997. Dietary sugar and colon cancer. Cancer Epidemiol Biomarkers Prev, 6(9), 677-685 .PMID: 9298574.
318. Slattery ML, Curtin K, Ma K, et al. 2002. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev, 11(6), 541-548 .PMID: 12050095.
319. Snover DC. 2011. Update on the serrated pathway to colorectal carcinoma. Hum Pathol, 42(1), 1-10 .PMID: 20869746.
320. Sostres C, Gargallo CJ, and Lanas A. 2014. Aspirin, cyclooxygenase inhibition and colorectal cancer. World J Gastrointest Pharmacol Ther, 5(1), 40-49 .PMCID: PMC3944468.
321. Soumaoro LT, Uetake H, Higuchi T, et al. 2004. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res, 10(24), 8465-8471 .PMID: 15623626.
322. Spirio L, Olschwang S, Groden J, et al. 1993. Alleles of the APC gene: an atten-uated form of familial polyposis. Cell, 75(5), 951-957 .PMID: 8252630.
323. Surveillance Epidemiology and End Results. 2015. Surveillance, Epidemiology, and End Results (SEER) Stat Fact Sheets: Colon and Rectum Cancer. Available from: http://seer.cancer.gov/statfacts/html/colorect.html Accessed January 5, 2016.
324. Svensson E, Moller B, Tretli S, et al. 2005. Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia. Cancer Causes Control, 16(3), 215-223 .PMID: 15947873.
325. Tadros M, and Anderson JC. 2013. Serrated polyps: clinical implications and future directions. Curr Gastroenterol Rep, 15(9), 342 .PMID: 23934652.
326. Taggarshe D, Rehil N, Sharma S, Flynn JC, and Damadi A. 2013. Colorectal cancer: are the "young" being overlooked? Am J Surg, 205(3), 312-316 .PMID: 23414955.
327. Takahashi M, and Wakabayashi K. 2004. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci, 95(6), 475-480 .PMID: 15182426.
328. Thiel A, and Ristimaki A. 2013. Toward a molecular classification of colorectal cancer: the role of BRAF. Front Oncol, 3, 281 .PMCID: PMC3828559.
329. Thissen JP, Ketelslegers JM, and Underwood LE. 1994. Nutritional regulation of the insulin-like growth factors. Endocr Rev, 15(1), 80-101 .PMID: 8156941.
330. Thomas D. 2010. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet, 11(4), 259-272 .PMCID: PMC2891422.
331. Thun Mj, Calle EE, Namboodiri MM, et al. 1992. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst, 84(19), 1491-1500 .PMID: 1433333.
332. Thun MJ, Jacobs EJ, and Patrono C. 2012. The role of aspirin in cancer preven-tion. Nat Rev Clin Oncol, 9(5), 259-267 .PMID: 22473097.
333. Tomasetti C, and Vogelstein B. 2015. Cancer etiology: variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science, 347(6217), 78-81 .PMCID: PMC4446723.
334. Torre LA, Siegel RL, Ward EM, and Jemal A. 2016. Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiol Biomarkers Prev, 25(1), 16-27 .PMID: 26667886.
335. Toyota M, Ahuja N, Ohe-Toyota M, et al. 1999. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A, 96(15), 8681-8686 .PMCID: PMC17576.
336. Toyota M, Ohe-Toyota M, Ahuja N, and Issa JP. 2000. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A, 97(2), 710-715 .PMCID: PMC15395.
337. Triantafillidis JK, Nasioulas G, and Kosmidis PA. 2009. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res, 29(7), 2727-2737 .PMID: 19596953.
338. Tsai S, and Gearhart S. 2011. Presentation and initial evaluation of colorectal cancer. In: Gearhart S, and Ahuja N (Eds.), Early Diagnosis and Treatment of Cancer (pp. 13-19). Philadelphia: Saunders Elsevier.
339. Tsoi KK, Pau CY, Wu WK, et al. 2009. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol, 7(6), 682-688 .PMID: 19245853.
340. Tuomilehto J, Knowler WC, and Zimmet P. 1992. Primary prevention of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev, 8(4), 339-353 .PMID: 1307523.
341. Turcotte LP, and Fisher JS. 2008. Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise. Phys Ther, 88(11), 1279-1296 .PMCID: PMC2579902.
342. Turesky RJ. 2004. The role of genetic polymorphisms in metabolism of carci-nogenic heterocyclic aromatic amines. Curr Drug Metab, 5(2), 169-180 .PMID: 15078194.
343. Turner ND, Ritchie LE, Bresalier RS, and Chapkin RS. 2013. The microbi- ome and colorectal neoplasia: environmental modifiers of dysbiosis. Curr Gastroenterol Rep, 15(9), 346 .PMCID: PMC3807587.
344. Ulrich CM. 2007. Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr, 86(2), 271-273 .PMID: 17684194.
345. Van Blarigan EL, and Meyerhardt JA. 2015. Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol, 33(16), 1825-1834 .PMCID: PMC4438267.
346. Vasen HF, Watson P, Mecklin JP, and Lynch HT. 1999. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 116(6), 1453-1456 .PMID: 10348829.
347. Vogelstein B, Fearon ER, Hamilton SR et al. 1988. Genetic alterations during colorectal-tumor development. N Engl J Med, 319(9), 525-532 .PMID: 2841597.
348. Vollset SE, Clark R, Lewington S, et al. 2013. Effects of folic acid supplemen-tation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet, 381(9871), 1029-1036 .PMCID: PMC3836669.
349. Wakai K, Date C, Fukui M, et al. 2007. Dietary fiber and risk of colorectal cancer in the Japan collaborative cohort study. Cancer Epidemiol Biomarkers Prev, 16(4), 668-675 .PMID: 17416756.
350. Wallace K, Baron JA, Cole BF, et al. 2004. Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst, 96(12), 921-925 .PMID: 15199111.
351. Wargovich MJ, Eng VW, and Newmark H. 1984. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett, 23(3), 253-258 .PMID: 6744249.
352. Warren JL, Klabunde CN, Mariotto AB, et al. 2009. Adverse events after outpa-tient colonoscopy in the Medicare population. Ann Intern Med, 150(12), 849-857, W152 .PMID: 19528563.
353. Wei EK, Giovannucci E, Wu K, et al. 2004. Comparison of risk factors for colon and rectal cancer. Int J Cancer, 108(3), 433-442 .PMCID: PMC2903217.
354. Wei EK, Ma J, Pollak MN et al. 2005. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev, 14(4), 850-855 .PMID: 15824155.
355. Weir JM, and Dunn JE, Jr. 1970. Smoking and mortality: a prospective study. Cancer, 25(1), 105-112 .PMID: 5410301.
356. Weisenberger DJ, Levine AJ, Long TI, et al. 2015. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history. Cancer Epidemiol Biomarkers Prev, 24(3), 512-519 .PMCID: PMC4355081.
357. Weisenberger DJ, Siegmund KD, Campan M, et al. 2006. CpG island methyl- ator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet, 38(7), 787-793 .PMID: 16804544.
358. Wheeler JM, Bodmer WF, and Mortensen NJ. 2000a. DNA mismatch repair genes and colorectal cancer. Gut, 47(1), 148-153 .PMCID: PMC1727951.
359. Wheeler JM, Loukola A, Aaltonen LA, Mortensen NJ, and Bodmer WF. 2000b. The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers. J Med Genet, 37(8), 588-592 .PMCID: PMC1734667.
360. Whiffin N, Hosking FJ, Farrington SM, et al. 2014. Identification of suscep-tibility loci for colorectal cancer in a genome-wide meta-analysis. Hum Mol Genet, 23(17), 4729-4737 .PMCID: PMC4133584.
361. Winawer SJ. 1999. Natural history of colorectal cancer. Am J Med, 106(1A), 3S-6S; discussion 50S-51S .PMID: 10089106.
362. Winawer SJ, Stewart ET, Zauber AG, et al. 2000. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med, 342(24), 1766-1772 .PMID: 10852998.
363. Winawer SJ, Zauber AG, O'Brien MJ, et al. 1993. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med, 328(13), 901-906 .PMID: 8446136.
364. Wolin KY, Lee IM, Colditz GA, et al. 2007. Leisure-time physical activity pat-terns and risk of colon cancer in women. Int J Cancer, 121(12), 2776-2781 .PMCID: PMC2291204.
365. Wolin KY, Yan Y, and Colditz GA. 2011. Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer, 104(5), 882-885 .PMCID: PMC3048199.
366. Wong NA, and Harrison DJ. 2001. Colorectal neoplasia in ulcerative colitis- recent advances. Histopathology, 39(3), 221-234 .PMID: 11532032.
367. Wu K, Feskanich D, Fuchs CS, et al. 2011. Interactions between plasma levels of 25-hydroxyvitamin D, insulin-t ike growth factor (IGF)-1 and C-peptide with risk of colorectal cancer. PLoS One, 6(12), e28520 .PMCID: PMC3247212.
368. Yamada Y, and Mori H. 2007. Multistep carcinogenesis of the colon in ApcMin/ + mouse. Cancer Sci, 98(1), 6-10 .PMID: 17052257.
369. Yamauchi M, Lochhead P, Morikawa T, et al. 2012. Colorectal cancer: a tale of two sides or a continuum? Gut, 61(6), 794-797 .PMCID: PMC3345045.
370. Yao X, and Tian Z. 2015. Dyslipidemia and colorectal cancer risk: a metaanalysis of prospective studies. Cancer Causes Control, 26(2), 257-268 .PMID: 25488827.
371. Yoon YS, Keum N, Zhang X, Cho E, and Giovannucci EL. 2015a. Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: a meta-analysis. Cancer Epidemiol, 39(6), 1026-1035 .PMID: 26388613.
372. Yoon YS, Keum N, Zhang X, Cho E, and Giovannucci EL. 2015b. Hyperinsulinemia, insulin resistance and colorectal adenomas: a meta-analysis. Metabolism, 64(10), 1324-1333 .PMID: 26169471.
373. Zauber AG, Winawer SJ, O'Brien MJ, et al. 2012. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med, 366(8), 687-696 .PMCID: PMC3322371.
374. Zhang B, Jia WH, Matsuda K et al. 2014. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk. Nat Genet, 46(6), 533-542 .PMCID: PMC4068797.
375. Zhang X, Wu K, Cho E, et al. 2013. Prospective cohort studies of bowel movement frequency and laxative use and colorectal cancer incidence in US women and men. Cancer Causes Control, 24(5), 1015-1024 .PMCID: PMC3633608.
376. Zhao C, Ge Z, Wang Y, and Qian J. 2012. Meta-analysis of observational studies on cholecystectomy and the risk of colorectal adenoma. Eur J Gastroenterol Hepatol, 24(4), 375-381 .PMID: 22410713.
377. Ziegler RG, Devesa SS, and Fraumeni JF, Jr. 1986. Epidemiologic patterns of colorectal cancer. In: DeVita VT, Hellman S, and Rosenberg SA (Eds.), Important Advances in Oncology (pp. 209-232). Philadelphia: J. B. Lippincott .PMID: 3330534.
378. Zorzi M, Fedeli U, Schievano E, et al. 2015. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut, 64(5), 784-790 .PMID: 25179811.